glp-1 anti-obesity GLP-1R Agonists for Weight Loss Anti-Obesity Drugs: What EM Physicians

Effects of Dichrostachys glomerata and Cissus quadrangularis extracts on GLP-1 secretion and DPP-4 activity in overweight and obese individuals: A randomized controlled trial

The evidence tracks the molecules: STEP for semaglutide in weight management (NEJM 2021), SURMOUNT for tirzepatide (NEJM 2022), and SURMOUNT-OSA for tirzepatide in obstructive sleep apnea (NEJM 2024)

Pay close attention to how different foods feel during and after eating, and youll build self-awareness that guides your next steps

Kojic Acid reduces pigmentation 2

Sleep apnea In 2024, the FDA approved Zepbound for the treatment of moderate to severe obstructive sleep apnea in adults with obesity, making it the first medication approved for sleep apnea

A subscription helps protect your progress by ensuring uninterrupted treatment as part of your personalised CheqUp programme